Similar articles for PMID: 33214332

Year	Number of Results
1965	2
1966	4
1967	4
1968	4
1969	3
1970	2
1973	2
1975	3
1976	2
1977	3
1978	2
1979	3
1981	3
1982	1
1984	4
1985	2
1986	1
1987	1
1988	2
1989	2
1990	2
1991	1
1992	3
1994	1
1995	1
1996	1
1998	1
1999	1
2000	1
2001	1
2002	1
2003	3
2005	1
2006	2
2007	1
2008	1
2009	1
2010	2
2013	4
2015	2
2016	2
2017	3
2018	3
2019	7
2020	6
2021	2

1

COVID-19 and Primary Measles Vaccination Rates in a Large Primary Care Network.

Bode SM, Gowda C, Mangini M, Kemper AR. Bode SM, et al. Pediatrics. 2021 Jan;147(1):e2020035576. doi: 10.1542/peds.2020-035576. Epub 2020 Nov 19. Pediatrics. 2021. PMID: 33214332 No abstract available.

2

Spotlight on measles 2010: preliminary report of an ongoing measles outbreak in a subpopulation with low vaccination coverage in Berlin, Germany, January-March 2010.

Bätzing-Feigenbaum J, Pruckner U, Beyer A, Sinn G, Dinter A, Mankertz A, Siedler A, Schubert A, Suckau M. Bätzing-Feigenbaum J, et al. Euro Surveill. 2010 Apr 1;15(13):19527. Euro Surveill. 2010. PMID: 20394713 Free article.

3

Temporal trend of measles cases and impact of vaccination on mortality in Jigawa State, Nigeria, 2013-2017: a secondary data analysis.

Faruk AS, Adebowale AS, Balogun MS, Taiwo L, Adeoye O, Mamuda S, Waziri NE. Faruk AS, et al. Pan Afr Med J. 2020 Feb 19;35(Suppl 1):13. doi: 10.11604/pamj.supp.2020.35.1.19780. eCollection 2020. Pan Afr Med J. 2020. PMID: 32373264 Free PMC article.

4

Impact of measles vaccination on childhood mortality in rural Bangladesh.

Koenig MA, Khan MA, Wojtyniak B, Clemens JD, Chakraborty J, Fauveau V, Phillips JF, Akbar J, Barua US. Koenig MA, et al. Bull World Health Organ. 1990;68(4):441-7. Bull World Health Organ. 1990. PMID: 2208557 Free PMC article.

5

Measles vaccination. Report of a large scale trial of further attenuated measles vaccine in Nigeria.

Hendrickse RG, Montefiore D, Peradze T, Sherman P, Powell M. Hendrickse RG, et al. J Trop Med Hyg. 1966 May;69(5):112-6. J Trop Med Hyg. 1966. PMID: 5941800 No abstract available.

6

Evaluation of measles vaccination programme conducted in two separate health centres.

Onoja AL, Adu FD, Tomori O. Onoja AL, et al. Vaccine. 1992;10(1):49-52. doi: 10.1016/0264-410x(92)90419-k. Vaccine. 1992. PMID: 1539460 Clinical Trial.

7

[Apropos of measles vaccination. Results of the first trials of antimeasles vaccination in France with hyperattenuated living virus vaccine].

Mande R, Jammet ML, Celers J, Boué A. Mande R, et al. Ann Pediatr (Paris). 1967 Jan 2;14(1):66-73. Ann Pediatr (Paris). 1967. PMID: 5597350 French. No abstract available.

8

Measles in Europe in 2001-2002.

Muscat M, Glismann S, Bang H. Muscat M, et al. Euro Surveill. 2003 Jun;8(6):123-9. doi: 10.2807/esm.08.06.00414-en. Euro Surveill. 2003. PMID: 12878801

9

Measles vaccination. V. The booster effect of purified hemagglutinin in children previously immunized with this product or formalin-killed vaccine.

Norrby E, Lagercrantz R, Gard S. Norrby E, et al. Acta Paediatr Scand. 1966 Jan;55(1):73-8. doi: 10.1111/j.1651-2227.1966.tb15210.x. Acta Paediatr Scand. 1966. PMID: 5919475 No abstract available.

10

Vaccination of infants in their first year of life with split inactivated measles vaccine incorporated in a diphtheriapertussis-tetanus-polio (inactivated) vaccine (DPTP-M), compared with live measles vaccination.

Brouwer R. Brouwer R. J Biol Stand. 1976;4(1):13-23. doi: 10.1016/0092-1157(76)90033-0. J Biol Stand. 1976. PMID: 943399 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed